FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3215890133> ?p ?o ?g. }

• W3215890133 endingPage "51" @default.
• W3215890133 startingPage "46" @default.
• W3215890133 abstract "Immune checkpoint inhibitors (ICI) have significantly improved outcome of patients with advanced NSCLC and recently also showed benefit in early-stage disease. Patients with oligometastatic disease (OMD) harbor limited metastases, resectable primary tumors and derive benefit from treatment with multimodal locally ablative and systemic therapy approaches. Nothing is known about feasibility and efficacy of neoadjuvant ICI in this setting.We here provide data from a multicenter retrospective study comprising 13 patients with NSCLC and OMD (≤3 distant metastases) from 5 university medical centers in Germany who have been treated with neoadjuvant ICI alone (n = 4) or in combination with chemotherapy (CT) (n = 9) prior to resection of the primary tumor. We analyzed complete (pCR) and major pathological remission (MPR) rates.These data show that neoadjuvant immunotherapy applied mostly in combination with CT results in high rates of pCR and MPR (54 and 69%, respectively). Up to now, 85% of patients are free of progression with a median follow-up of 9 months (3-28 months). Single cell RNASeq analysis of tumor tissue from one patient treated with CT-ICI indicates a strong predominance of adaptive immune cell populations over a small minority of epithelial (tumor) cells.Neoadjuvant ICI with or without CT is a promising therapeutic concept in patients with OMD." @default.
• W3215890133 created "2021-12-06" @default.
• W3215890133 creator A5008375346 @default.
• W3215890133 creator A5013804417 @default.
• W3215890133 creator A5019037335 @default.
• W3215890133 creator A5022181207 @default.
• W3215890133 creator A5028935333 @default.
• W3215890133 creator A5030958975 @default.
• W3215890133 creator A5031448289 @default.
• W3215890133 creator A5033347480 @default.
• W3215890133 creator A5034434819 @default.
• W3215890133 creator A5047664676 @default.
• W3215890133 creator A5052962511 @default.
• W3215890133 creator A5053291675 @default.
• W3215890133 creator A5055352107 @default.
• W3215890133 creator A5074524521 @default.
• W3215890133 creator A5082989165 @default.
• W3215890133 date "2022-02-01" @default.
• W3215890133 modified "2023-10-01" @default.
• W3215890133 title "Pathologic responses in oligometastatic NSCLC patients treated with neoadjuvant immune checkpoint blockade with and without chemotherapy followed by surgery" @default.
• W3215890133 cites W2019204011 @default.
• W3215890133 cites W2019607817 @default.
• W3215890133 cites W2521503673 @default.
• W3215890133 cites W2944301866 @default.
• W3215890133 cites W3033779930 @default.
• W3215890133 cites W3154805493 @default.
• W3215890133 cites W3165887339 @default.
• W3215890133 cites W3178223947 @default.
• W3215890133 cites W3183360624 @default.
• W3215890133 cites W3198128201 @default.
• W3215890133 doi "https://doi.org/10.1016/j.lungcan.2021.11.009" @default.
• W3215890133 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34998106" @default.
• W3215890133 hasPublicationYear "2022" @default.
• W3215890133 type Work @default.
• W3215890133 sameAs 3215890133 @default.
• W3215890133 citedByCount "3" @default.
• W3215890133 countsByYear W32158901332022 @default.
• W3215890133 countsByYear W32158901332023 @default.
• W3215890133 crossrefType "journal-article" @default.
• W3215890133 hasAuthorship W3215890133A5008375346 @default.
• W3215890133 hasAuthorship W3215890133A5013804417 @default.
• W3215890133 hasAuthorship W3215890133A5019037335 @default.
• W3215890133 hasAuthorship W3215890133A5022181207 @default.
• W3215890133 hasAuthorship W3215890133A5028935333 @default.
• W3215890133 hasAuthorship W3215890133A5030958975 @default.
• W3215890133 hasAuthorship W3215890133A5031448289 @default.
• W3215890133 hasAuthorship W3215890133A5033347480 @default.
• W3215890133 hasAuthorship W3215890133A5034434819 @default.
• W3215890133 hasAuthorship W3215890133A5047664676 @default.
• W3215890133 hasAuthorship W3215890133A5052962511 @default.
• W3215890133 hasAuthorship W3215890133A5053291675 @default.
• W3215890133 hasAuthorship W3215890133A5055352107 @default.
• W3215890133 hasAuthorship W3215890133A5074524521 @default.
• W3215890133 hasAuthorship W3215890133A5082989165 @default.
• W3215890133 hasConcept C121608353 @default.
• W3215890133 hasConcept C126322002 @default.
• W3215890133 hasConcept C143998085 @default.
• W3215890133 hasConcept C146357865 @default.
• W3215890133 hasConcept C151730666 @default.
• W3215890133 hasConcept C170493617 @default.
• W3215890133 hasConcept C203014093 @default.
• W3215890133 hasConcept C207886595 @default.
• W3215890133 hasConcept C2776694085 @default.
• W3215890133 hasConcept C2777701055 @default.
• W3215890133 hasConcept C2778292576 @default.
• W3215890133 hasConcept C2778468042 @default.
• W3215890133 hasConcept C2779013556 @default.
• W3215890133 hasConcept C2780283643 @default.
• W3215890133 hasConcept C2780851360 @default.
• W3215890133 hasConcept C530470458 @default.
• W3215890133 hasConcept C71924100 @default.
• W3215890133 hasConcept C86803240 @default.
• W3215890133 hasConcept C8891405 @default.
• W3215890133 hasConceptScore W3215890133C121608353 @default.
• W3215890133 hasConceptScore W3215890133C126322002 @default.
• W3215890133 hasConceptScore W3215890133C143998085 @default.
• W3215890133 hasConceptScore W3215890133C146357865 @default.
• W3215890133 hasConceptScore W3215890133C151730666 @default.
• W3215890133 hasConceptScore W3215890133C170493617 @default.
• W3215890133 hasConceptScore W3215890133C203014093 @default.
• W3215890133 hasConceptScore W3215890133C207886595 @default.
• W3215890133 hasConceptScore W3215890133C2776694085 @default.
• W3215890133 hasConceptScore W3215890133C2777701055 @default.
• W3215890133 hasConceptScore W3215890133C2778292576 @default.
• W3215890133 hasConceptScore W3215890133C2778468042 @default.
• W3215890133 hasConceptScore W3215890133C2779013556 @default.
• W3215890133 hasConceptScore W3215890133C2780283643 @default.
• W3215890133 hasConceptScore W3215890133C2780851360 @default.
• W3215890133 hasConceptScore W3215890133C530470458 @default.
• W3215890133 hasConceptScore W3215890133C71924100 @default.
• W3215890133 hasConceptScore W3215890133C86803240 @default.
• W3215890133 hasConceptScore W3215890133C8891405 @default.
• W3215890133 hasLocation W32158901331 @default.
• W3215890133 hasLocation W32158901332 @default.
• W3215890133 hasOpenAccess W3215890133 @default.
• W3215890133 hasPrimaryLocation W32158901331 @default.
• W3215890133 hasRelatedWork W1964795883 @default.
• W3215890133 hasRelatedWork W2300188460 @default.

• next